AMC Entertainment Holdings, Inc. (NYSE:AMC) (the "Company," or "AMC"), today released preliminary results for the first quarter ended March 31, 2024. The preliminary results are unaudited, subject to completion of the

AMC

M&A
News

Monster Enters Into Asset Purchase Agreement With Vital Pharmaceuticals; Monster Would Acquire Substantially All Of Bang Energy’s Assets, Including A Beverage Production Facility Located In Phoenix, AZ. The Transaction Is Subject To Certain Terms And C…

By Benzinga Newsdesk

July 3, 8:09 AM

Proposed Transaction to Capitalize on Growing Energy Drink Category Vital Pharmaceuticals filed for Chapter 11 Protection in October 2022

MNST

Analyst Ratings

24 Analysts Have This to Say About Sarepta Therapeutics

By Benzinga Insights

June 6, 11:00 AM

Sarepta Therapeutics (NASDAQ:SRPT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

SRPT

Citigroup Upgrades Core Laboratories to Neutral

Related Posts

Truist Securities Maintains Buy on Roku, Lowers Price Target to $90

AMC Entertainment Holdings, Inc. Previews Q1 2024 Preliminary Results; Sees Q1 EPS $(0.62) Vs $(0.79) Est.; Revenue $951.4M Vs $861.06M Est.

Monster Enters Into Asset Purchase Agreement With Vital Pharmaceuticals; Monster Would Acquire Substantially All Of Bang Energy’s Assets, Including A Beverage Production Facility Located In Phoenix, AZ. The Transaction Is Subject To Certain Terms And C…

24 Analysts Have This to Say About Sarepta Therapeutics